Building Blocks
Cette section contient des produits fondamentaux pour la synthèse de composés organiques et biologiques. Building blocks sont les matériaux de départ essentiels utilisés pour construire des molécules complexes à travers diverses réactions chimiques. Ils jouent un rôle crucial dans la découverte de médicaments, la science des matériaux et la recherche chimique. Chez CymitQuimica, nous offrons une gamme diversifiée de building blocks de haute qualité pour soutenir vos recherches innovantes et projets industriels, en vous assurant de disposer des composants essentiels pour une synthèse réussie.
Sous-catégories appartenant à la catégorie "Building Blocks"
- Acides boroniques et dérivés de l'acide boronique(5.778 produits)
- Building Blocks Chiraux(1.243 produits)
- Building Blocks Hydrocarbonés(6.097 produits)
- Building Blocks organiques(61.052 produits)
201390 produits trouvés pour "Building Blocks"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
3-{1-[(4-Chlorophenyl)methyl]-1H-indol-3-yl}propanoic acid
CAS :Produit contrôlé<p>Versatile small molecule scaffold</p>Formule :C18H16ClNO2Degré de pureté :Min. 95%Masse moléculaire :313.8 g/molRef: 3D-UIA54454
Produit arrêtérac-(2R,5S)-5-[(1H-Pyrazol-1-yl)methyl]oxolane-2-carboxylic acid hydrochloride
CAS :<p>Versatile small molecule scaffold</p>Formule :C9H13ClN2O3Degré de pureté :Min. 95%Masse moléculaire :232.7 g/molrac-2,2,2-Trifluoro-N-[(3R,4S)-4-(3-fluoro-4-methoxyphenyl)piperidin-3-yl]acetamide
CAS :<p>Versatile small molecule scaffold</p>Formule :C14H16F4N2O2Degré de pureté :Min. 95%Masse moléculaire :320.28 g/mol(4,4,4-Trifluoro-2-nitrobut-2-en-1-yl)benzene
CAS :<p>Versatile small molecule scaffold</p>Formule :C10H8F3NO2Degré de pureté :Min. 95%Masse moléculaire :231.17 g/mol5-Chloro-N-propyl-1,2-benzoxazol-3-amine
CAS :<p>Versatile small molecule scaffold</p>Formule :C10H11ClN2ODegré de pureté :Min. 95%Masse moléculaire :210.66 g/mol1-(2-(2-Methoxyethoxy)ethyl)-1H-pyrazole-5-carboxylic acid
CAS :<p>Versatile small molecule scaffold</p>Formule :C9H14N2O4Degré de pureté :Min. 95%Masse moléculaire :214.22 g/mol[5-Methyl-2-(oxolan-3-ylmethoxy)phenyl]methanol
CAS :<p>Versatile small molecule scaffold</p>Formule :C13H18O3Degré de pureté :Min. 95%Masse moléculaire :222.28 g/mol5-(4-Methyl-4H-1,2,4-triazol-3-yl)pyridin-3-amine
CAS :<p>Versatile small molecule scaffold</p>Formule :C8H9N5Degré de pureté :Min. 95%Masse moléculaire :175.19 g/mol1-Methoxy-3-(2-methylmorpholin-4-yl)propan-2-ol
CAS :<p>Versatile small molecule scaffold</p>Formule :C9H19NO3Degré de pureté :Min. 95%Masse moléculaire :189.25 g/mol(4-Methoxypyridin-2-yl)methanamine dihydrochloride
CAS :<p>Versatile small molecule scaffold</p>Formule :C7H12Cl2N2ODegré de pureté :Min. 95%Masse moléculaire :211.09 g/mol2-[4-(4-Fluorophenyl)piperazin-1-yl]propanoic acid dihydrochloride
CAS :<p>Versatile small molecule scaffold</p>Formule :C13H19Cl2FN2O2Degré de pureté :Min. 95%Masse moléculaire :325.2 g/mol5-(Aminomethyl)-N-methyl-2-furamide hydrochloride
CAS :<p>Versatile small molecule scaffold</p>Formule :C7H11ClN2O2Degré de pureté :Min. 95%Masse moléculaire :190.63 g/mol3-Hydroxy-1-methylpyrrolidine-2,5-dione
CAS :<p>3-Hydroxy-1-methylpyrrolidine-2,5-dione is a chemical compound that is used as an intermediate in the synthesis of various pharmaceuticals. It is not known to have any direct health effects on humans. 3-Hydroxy-1-methylpyrrolidine-2,5-dione has been detected in human urine and plasma samples by GC/MS and LC/MS methods. The detection limit of this substance in urine and plasma has been reported to be 0.05 ng/mL. Monitoring studies have shown that 3-hydroxy-1 methylpyrrolidine 2,5 dione can be found at levels up to 1 ppm in the general population.</p>Formule :C5H7NO3Degré de pureté :Min. 95%Masse moléculaire :129.11 g/molRef: 3D-UAA94827
Produit arrêtéN-{[5-(4-Nitrophenyl)furan-2-yl]methylidene}hydroxylamine
CAS :<p>Versatile small molecule scaffold</p>Formule :C11H8N2O4Degré de pureté :Min. 95%Masse moléculaire :232.19 g/mol4-(Diphenylmethyl)piperidine
CAS :Produit contrôlé<p>4-(Diphenylmethyl)piperidine is a molecule that has been used to study the effects of dimethylsulfate on pancreatic cells. It can also be used to induce diabetes in humans and animals. 4-(Diphenylmethyl)piperidine binds to chloride ions in the cytoplasm and isomers are formed, which may have an effect on cell morphology and cell toxicity. This drug does not have any pharmacologic activity in humans or animals, but it has been shown to be diabetogenic in animal models.</p>Formule :C18H21NDegré de pureté :Min. 95%Masse moléculaire :251.4 g/molN-(2-Cyanoethyl)-N-(propan-2-yl)methanesulfonamide
CAS :<p>Versatile small molecule scaffold</p>Formule :C7H14N2O2SDegré de pureté :Min. 95%Masse moléculaire :190.27 g/molRef: 3D-TUB78768
Produit arrêté2-(3-Aminophenyl)-6-methyl-3,4-dihydropyrimidin-4-one
CAS :<p>Versatile small molecule scaffold</p>Formule :C11H11N3ODegré de pureté :Min. 95%Masse moléculaire :201.22 g/mol3-(3-Fluorophenyl)-2-(5-methyl-1H-1,2,3,4-tetrazol-1-yl)propanoic acid
CAS :Produit contrôlé<p>3-(3-Fluorophenyl)-2-(5-methyl-1H-1,2,3,4-tetrazol-1-yl)propanoic acid is a potent activator of GABAA receptors. It has been shown to have high affinity for GABA binding sites and is able to activate the receptor with an EC50 of around 100 nM. It also has no effect on other receptors that are structurally related to GABA, such as glycine and 5HT3 receptors. 3-(3-Fluorophenyl)-2-(5-methyl-1H-1,2,3,4-tetrazol-1-yl)propanoic acid is soluble in DMSO and ethanol.</p>Formule :C11H11FN4O2Degré de pureté :Min. 95%Masse moléculaire :250.23 g/molRef: 3D-TUB78720
Produit arrêté5-Ethyl-4-(4-methoxy-phenyl)-thiazol-2-ylamine
CAS :<p>Versatile small molecule scaffold</p>Formule :C12H14N2OSDegré de pureté :Min. 95%Masse moléculaire :234.32 g/molRef: 3D-TUA02820
Produit arrêtérac-(2R,3S)-3-(Ethoxycarbonyl)pyrrolidine-2-carboxylic acid
CAS :<p>Versatile small molecule scaffold</p>Formule :C8H13NO4Degré de pureté :Min. 95%Masse moléculaire :187.2 g/mol{1-Methyl-2-oxabicyclo[2.2.1]heptan-4-yl}methanamine hydrochloride
CAS :<p>Versatile small molecule scaffold</p>Formule :C8H16ClNODegré de pureté :Min. 95%Masse moléculaire :177.7 g/mol7-Amino-2H,3H,5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridin-3-one hydrochloride
CAS :<p>Versatile small molecule scaffold</p>Formule :C6H11ClN4ODegré de pureté :Min. 95%Masse moléculaire :190.6 g/mol{8,8-Difluorobicyclo[5.1.0]octan-4-yl}methanamine hydrochloride
CAS :<p>Versatile small molecule scaffold</p>Formule :C9H16ClF2NDegré de pureté :Min. 95%Masse moléculaire :211.7 g/mol2-(6,6-Dimethylmorpholin-2-yl)acetamide hydrochloride
CAS :<p>Versatile small molecule scaffold</p>Formule :C8H17ClN2O2Degré de pureté :Min. 95%Masse moléculaire :208.7 g/mol2-Amino-3-(oxolan-3-yl)propanoic acid hydrochloride
CAS :<p>Versatile small molecule scaffold</p>Formule :C7H14ClNO3Degré de pureté :Min. 95%Masse moléculaire :195.64 g/molRef: 3D-TPD50859
Produit arrêté1-(4-Bromo-2,6-dimethylphenyl)piperidin-3-amine
CAS :<p>Versatile small molecule scaffold</p>Formule :C13H19BrN2Degré de pureté :Min. 95%Masse moléculaire :283.21 g/mol5-(Fur-2-yl)thiophene-2-carboxylic acid
CAS :<p>Versatile small molecule scaffold</p>Formule :C9H6O3SDegré de pureté :Min. 95%Masse moléculaire :194.21 g/molRef: 3D-TJB75562
Produit arrêté2-(5-Bromo-1H-indol-2-yl)propan-2-ol
CAS :<p>Versatile small molecule scaffold</p>Formule :C11H12BrNODegré de pureté :Min. 95%Masse moléculaire :254.12 g/mol5-(Trifluoromethyl)benzo[D]isoxazol-3-amine
CAS :<p>Versatile small molecule scaffold</p>Formule :C8H5F3N2ODegré de pureté :Min. 95%Masse moléculaire :202.14 g/molRef: 3D-TJB27114
Produit arrêtéEthyl 2-ethyl-2-(hydroxymethyl)butanoate
CAS :<p>Versatile small molecule scaffold</p>Formule :C9H18O3Degré de pureté :Min. 95%Masse moléculaire :174.24 g/mol1-{5H,6H,7H,8H-Pyrido[4,3-c]pyridazin-3-yl}pyrrolidine dihydrochloride
CAS :<p>Versatile small molecule scaffold</p>Formule :C11H18Cl2N4Degré de pureté :Min. 95%Masse moléculaire :277.2 g/mol3,4-Dihydro-1H-2-benzothiopyran-4-amine hydrochloride
CAS :<p>Versatile small molecule scaffold</p>Formule :C9H12ClNSDegré de pureté :Min. 95%Masse moléculaire :201.72 g/molRef: 3D-TFA12783
Produit arrêté2-{5H,6H,7H-Cyclopenta[D]pyrimidin-2-yl}ethan-1-amine
CAS :<p>Versatile small molecule scaffold</p>Formule :C9H13N3Degré de pureté :Min. 95%Masse moléculaire :163.22 g/mol1-[1-Methyl-3-(oxan-4-yl)-1H-pyrazol-5-yl]ethan-1-one
CAS :<p>Versatile small molecule scaffold</p>Formule :C11H16N2O2Degré de pureté :Min. 95%Masse moléculaire :208.26 g/mol3-Cyano-5-methylpyrazolo[1,5-a]pyrimidine-6-carboxylic acid
CAS :<p>Versatile small molecule scaffold</p>Formule :C9H6N4O2Degré de pureté :Min. 95%Masse moléculaire :202.2 g/mol3-(6-Oxo-1,6-dihydropyrimidin-1-yl)propanoic acid
CAS :<p>Versatile small molecule scaffold</p>Formule :C7H8N2O3Degré de pureté :Min. 95%Masse moléculaire :168.15 g/molRef: 3D-SDC97378
Produit arrêté4-(3,4-dichlorophenyl)butan-2-one
CAS :<p>Versatile small molecule scaffold</p>Formule :C10H10OCl2Degré de pureté :Min. 95%Masse moléculaire :217.09 g/molMethyl 5-bromo-2-formylbenzoate
CAS :<p>Versatile small molecule scaffold</p>Formule :C9H7BrO3Degré de pureté :Min. 95%Masse moléculaire :243.05 g/molRef: 3D-RQB16389
Produit arrêté2-{1-[(tert-Butoxy)carbonyl]piperidin-4-yl}cyclopentane-1-carboxylic acid
CAS :<p>Versatile small molecule scaffold</p>Formule :C16H27NO4Degré de pureté :Min. 95%Masse moléculaire :297.4 g/molrac-(2R,3S)-5-Oxo-3-phenyl-4-(propan-2-yl)piperazine-2-carboxylic acid hydrochloride
CAS :<p>Versatile small molecule scaffold</p>Formule :C14H19ClN2O3Degré de pureté :Min. 95%Masse moléculaire :298.8 g/mol(3-Chloro-4-fluorophenyl)(phenyl)methanamine hydrochloride
CAS :<p>Versatile small molecule scaffold</p>Formule :C13H12Cl2FNDegré de pureté :Min. 95%Masse moléculaire :272.1 g/mol2-{[2-(3-Methoxyphenyl)phenyl]methyl}piperidine hydrochloride
CAS :<p>Versatile small molecule scaffold</p>Formule :C19H24ClNODegré de pureté :Min. 95%Masse moléculaire :317.9 g/molrac-[(1R,3S)-2,2-Difluoro-3-methylcyclopropyl]methanamine hydrochloride
CAS :<p>Versatile small molecule scaffold</p>Formule :C5H10ClF2NDegré de pureté :Min. 95%Masse moléculaire :157.6 g/mol[1-Methyl-4-(morpholin-4-yl)piperidin-4-yl]methanamine
CAS :<p>Versatile small molecule scaffold</p>Formule :C11H23N3ODegré de pureté :Min. 95%Masse moléculaire :213.32 g/molN-(Prop-2-yn-1-yl)pyridine-2-carboxamide
CAS :<p>Versatile small molecule scaffold</p>Formule :C9H8N2ODegré de pureté :Min. 95%Masse moléculaire :160.17 g/molN5-(2-Methoxyethyl)-N5-methylpyridine-2,5-diamine
CAS :<p>Versatile small molecule scaffold</p>Formule :C9H15N3ODegré de pureté :Min. 95%Masse moléculaire :181.23 g/molPyrazolo[1,5-a]pyridin-4-ol
CAS :<p>Pyrazolo[1,5-a]pyridin-4-ol is a heteroaromatic compound that acts as an inhibitor of phosphodiesterase (PDE). It prevents the breakdown of cyclic nucleotides and thus leads to increased levels of cAMP and cGMP. Pyrazolo[1,5-a]pyridin-4-ol has been shown to have bronchodilatory activity in animal models. The drug also inhibits the production of inflammatory mediators such as prostaglandins by inhibiting cyclooxygenases. In addition, pyrazolo[1,5-a]pyridin-4-ol has been shown to be a potential PDE inhibitor replacement for the more commonly used PDE inhibitors such as sildenafil and tadalafil. However, due to its lack of stereochemistry and its bicyclic chemical structure, pyrazolo[1,5-a]</p>Formule :C7H6N2ODegré de pureté :Min. 95%Masse moléculaire :134.14 g/molRef: 3D-RFA03272
Produit arrêté6-(3-Methylbutoxy)pyridazin-3-amine
CAS :<p>Versatile small molecule scaffold</p>Formule :C9H15N3ODegré de pureté :Min. 95%Masse moléculaire :181.23 g/mol1-(3-Methyl-isothiazol-5-yl)-ethanone
CAS :<p>Versatile small molecule scaffold</p>Formule :C6H7NOSDegré de pureté :Min. 95%Masse moléculaire :141.19 g/mol2,2-Diethyl-4-methoxy-4-oxobutanoic acid
CAS :<p>Versatile small molecule scaffold</p>Formule :C9H16O4Degré de pureté :Min. 95%Masse moléculaire :188.22 g/mol
